NeurologyLive® Friday 5 — March 31, 2023

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive^®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Differences in Diagnosis and Prevention Between NMOSD and MS

Michael Levy, MD, PhD, an associate professor at Harvard Medical School, sat down in an interview with NeurologyLive® to discuss notable research topics in the field of NMOSD and the current understanding of the disease in relation to MS.

2: Peer Exchange: Progression of NMOSD Over Time

In episode 4 of this Peer Exchange series on "Updates in the Management of Neuromyelitis Optica Spectrum Disorder Care (NMOSD)", experts in neurology provide an overview of NMOSD and discuss recent approvals and updates in the treatment and management of this condition.

3: NeuroVoices: Orrin Devinsky, MD, on Metabolic Changes and Benefits of Modified Atkins Diet in Epilepsy Surgery

In the latest edition of our in-depth Q&A series, the director of the Comprehensive Epilepsy Center at NYU Langone provided perspective on the advantages modified Atkins diets bring to patients with epilepsy and those considering epilepsy surgery.

4: Neuro News Roundup: Purple Day

For Purple Day — March 26, 2023 —the team has culminated some of the biggest pieces of news to offer updates on new developments in literature in epilepsy to spread awareness on the prevention and treatment of seizures.

5: Improvements in Awareness of NMOSD, Optic Neuritis: John Chen, MD, PhD

The neuroophthalmologist at mayo clinic sat down to discuss the importance of raising awareness for NMOSD, the education needed for a range of specialists who might encounter NMOSD or related disorders, as well as how advances in MOG-antibody disease has improved the overall detection of NMOSD. [WATCH TIME: 3 minutes]